Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
Rong En Tay, Emma K. Richardson, Han Chong Toh
Cancer Gene Therapy (2020) Vol. 28, Iss. 1-2, pp. 5-17
Open Access | Times Cited: 631

Showing 1-25 of 631 citing articles:

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 473
Metastatic colorectal cancer: mechanisms and emerging therapeutics
Alice E. Shin, Filippo G. Giancotti, Anil K. Rustgi
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 4, pp. 222-236
Open Access | Times Cited: 256
Understanding the tumor microenvironment for effective immunotherapy
Habib Sadeghi Rad, James Monkman, Majid Ebrahimi Warkiani, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1474-1498
Open Access | Times Cited: 230
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 221
Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
Colby S. Shemesh, Joy Hsu, Iraj Hosseini, et al.
Molecular Therapy (2020) Vol. 29, Iss. 2, pp. 555-570
Open Access | Times Cited: 203
Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade
Natalija Budimir, Graham D. Thomas, Joseph S. Dolina, et al.
Cancer Immunology Research (2021) Vol. 10, Iss. 2, pp. 146-153
Open Access | Times Cited: 181
CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?
Alexandra Miggelbrink, Joshua Jackson, Selena Lorrey, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 21, pp. 5742-5752
Open Access | Times Cited: 171
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment
Ayana T. Ruffin, Housaiyin Li, Lazar Vujanović, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 3, pp. 173-188
Open Access | Times Cited: 151
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
Alicia Cristina Peña-Romero, Esteban Orenes‐Piñero
Cancers (2022) Vol. 14, Iss. 7, pp. 1681-1681
Open Access | Times Cited: 148
Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
Pritha Agarwalla, Edikan A. Ogunnaike, Sarah Ahn, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 8, pp. 1250-1258
Open Access | Times Cited: 126
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Alexander J. Stephens, N. Burgess-Brown, Shisong Jiang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 117
CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 115
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 113
Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors
Laurel B. Darragh, Jacob Gadwa, Tiffany Pham, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 111
Development of Peptide-Based Vaccines for Cancer
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 92
Challenges in developing personalized neoantigen cancer vaccines
Peter D. Katsikis, Ken J. Ishii, Christopher Schliehe
Nature reviews. Immunology (2023) Vol. 24, Iss. 3, pp. 213-227
Closed Access | Times Cited: 86
Single cell cancer epigenetics
Marta Casado-Peláez, Alberto Bueno-Costa, Manel Esteller
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 820-838
Open Access | Times Cited: 77
Eosinophil–lymphocyte interactions in the tumor microenvironment and cancer immunotherapy
Sharon Grisaru‐Tal, Marc E. Rothenberg, Ariel Munitz
Nature Immunology (2022) Vol. 23, Iss. 9, pp. 1309-1316
Open Access | Times Cited: 75
Disease-associated metabolic pathways affected by heavy metals and metalloid
Zinia Haidar, Kaniz Fatema, Sabrina Samad Shoily, et al.
Toxicology Reports (2023) Vol. 10, pp. 554-570
Open Access | Times Cited: 74
Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer
Ruozheng Wei, Yuning Zhou, Chang Li, et al.
Cancer Research (2022) Vol. 82, Iss. 8, pp. 1575-1588
Open Access | Times Cited: 71
T Cell Exhaustion
Andrew Baessler, Dario A.A. Vignali
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 179-206
Closed Access | Times Cited: 67
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity
Morgane Boulch, Marine Cazaux, Alexis Cuffel, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 968-983
Open Access | Times Cited: 66
PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies
Ke Xin Lin, Alexandra C. Istl, Douglas Quan, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 3875-3893
Open Access | Times Cited: 47
Unsupervised and supervised discovery of tissue cellular neighborhoods from cell phenotypes
Yuxuan Hu, Jiazhen Rong, Yafei Xu, et al.
Nature Methods (2024) Vol. 21, Iss. 2, pp. 267-278
Open Access | Times Cited: 25
Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors
Dania Zhivaki, Stephanie N. Kennedy, J. Park, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3888-3903.e18
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top